The high-ranked pharmaceutical companies now have jumped into co-development of new improved drugs… while risk decreases, competition intensifies

Business trends in the pharmaceutical industry have been changed into a consortium form of participation with multiple pharmaceutical companies to develop a newimproved drug.

Especially, the high-ranked pharmaceutical companies, which had given lukewarm responses towards joint development, have shown active actions, too.

It is analyzed that the companies are leaning towardsmore on co-developm...